RU95121639A - Аза циклогексапептидные соединения - Google Patents

Аза циклогексапептидные соединения

Info

Publication number
RU95121639A
RU95121639A RU95121639/04A RU95121639A RU95121639A RU 95121639 A RU95121639 A RU 95121639A RU 95121639/04 A RU95121639/04 A RU 95121639/04A RU 95121639 A RU95121639 A RU 95121639A RU 95121639 A RU95121639 A RU 95121639A
Authority
RU
Russia
Prior art keywords
compound according
iii
dimethyltridecyl
conh
alkyl
Prior art date
Application number
RU95121639/04A
Other languages
English (en)
Other versions
RU2122548C1 (ru
Inventor
М.Балковек Джеймс
Эйлин Буффард Фрэнсис
М.Блэк Регина
Original Assignee
Мерк энд Ко. Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/032,847 external-priority patent/US5378804A/en
Application filed by Мерк энд Ко. Инк. filed Critical Мерк энд Ко. Инк.
Publication of RU95121639A publication Critical patent/RU95121639A/ru
Application granted granted Critical
Publication of RU2122548C1 publication Critical patent/RU2122548C1/ru

Links

Claims (14)

1. Соединение формулы
Figure 00000001

где R1 - H или OH;
R2 - H, CH3 или OH;
R3 - H, CH3, CH2CN, CH2CH2NH2 или CH2CONH2;
RI - C9 - C21алкил, C9 - C21алкенил, C1-C10алкоксифенил или C1-C10алкоксинафтил;
RII - H, C1 - C4алкил, C3-C4алкенил, (CH2)2-4OH, (CH2)2-4NRIVRV, CO(CH2)1-4NH2;
RIII - H, C1 - C4алкил, C3 - C4алкенил, (CH2)2-4OH, (CH2)2-4NRIVRV
или
RII и RIII взятые вместе - (CH2)4-, -(CH2)5-, -(CH2)2O(CH2)2-, -(CH2)2NH(CH2)2-;
RIV - H или C1 - C4алкил;
RV - H или C1 - C4алкил;
и их аддитивные соли кислоты.
2. Соединение по п.1, где R1 - OH, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII - H и RIII - CH2CH2NH2.
3. Соединение по п.1, где R1 - OH, R2 - H, R3 - CH2CH2NH2, RI - 9,11-диметилтридецил, RII - H и RIII - CH2CH2NH2.
4. Соединение по п.1, где R1 - OH, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII и RIII - H.
5. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII и RIII - H.
6. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII и RIII - COCH2CH2NH2.
7. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CONH2, RI - 9,11-диметилтридецил, RII - Н и RIII - CH2CH2NH2.
8. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CH2NH2, RI - 9,11-диметилтридецил, RII и RIII - H.
9. Соединение по п.1, где R1 - H, R2 - H, R3 - CH2CH2NH2, RI - 9,11-диметилтридецил, RII - H и RIII - CH2CH2NH2.
10. Антимикробная композиция, включающая в себя соединение по п.1 в смеси с фармацевтически приемлемым носителем.
11. Антимикробная композиция, включающая в себя соединение по п.2 в смеси с фармацевтически приемлемым носителем.
12. Способ лечения грибковых инфекций, включающий в себя введение противогрибковой дозы соединения по п.1 особям рода млекопитающих в лечебных целях.
13. Способ лечения пневмоцистической пневмонии у пациентов с пониженным иммунитетом, включающий в себя введение терапевтически эффективной дозы соединения по п.1.
14. Соединение формулы
Figure 00000002
;
RU95121639A 1993-03-16 1994-03-10 Циклические пептиды или их аддитивные соли кислоты, композиция, проявляющая противогрибковую и антипневмоцистную активность, способ лечения грибковых инфекций RU2122548C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US032847 1993-03-16
US08/032,847 US5378804A (en) 1993-03-16 1993-03-16 Aza cyclohexapeptide compounds

Publications (2)

Publication Number Publication Date
RU95121639A true RU95121639A (ru) 1997-09-20
RU2122548C1 RU2122548C1 (ru) 1998-11-27

Family

ID=21867140

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95121639A RU2122548C1 (ru) 1993-03-16 1994-03-10 Циклические пептиды или их аддитивные соли кислоты, композиция, проявляющая противогрибковую и антипневмоцистную активность, способ лечения грибковых инфекций

Country Status (33)

Country Link
US (3) US5378804A (ru)
EP (1) EP0620232B1 (ru)
JP (1) JP2568474B2 (ru)
KR (1) KR100329693B1 (ru)
CN (1) CN1098274C (ru)
AT (1) ATE186736T1 (ru)
AU (1) AU668804B2 (ru)
BG (1) BG63047B1 (ru)
BR (2) BR9406009A (ru)
CA (1) CA2118757C (ru)
CZ (1) CZ286235B6 (ru)
DE (2) DE69421639T2 (ru)
DK (1) DK0620232T3 (ru)
ES (1) ES2139043T3 (ru)
FI (1) FI109542B (ru)
GR (1) GR3031872T3 (ru)
HK (1) HK1008674A1 (ru)
HR (1) HRP940161B1 (ru)
HU (2) HU217614B (ru)
IL (1) IL108892A (ru)
LU (1) LU90875I2 (ru)
LV (1) LV12574B (ru)
NL (1) NL300076I2 (ru)
NO (2) NO318372B1 (ru)
NZ (1) NZ263360A (ru)
PL (1) PL179261B1 (ru)
RO (1) RO113246B1 (ru)
RU (1) RU2122548C1 (ru)
SI (1) SI9420013B (ru)
SK (1) SK282527B6 (ru)
UA (1) UA59329C2 (ru)
WO (1) WO1994021677A1 (ru)
ZA (1) ZA941807B (ru)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874403A (en) * 1992-10-15 1999-02-23 Merck & Co., Inc. Amino acid conjugates of cyclohexapeptidyl amines
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
DE69513408T2 (de) * 1994-08-23 2000-06-08 Merck & Co Inc Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl-lipopeptiden
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
CA2211138A1 (en) * 1995-01-26 1996-08-01 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5552521A (en) * 1995-02-10 1996-09-03 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
EP0862579A1 (en) * 1995-11-09 1998-09-09 Merck & Co., Inc. Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
HRP970318B1 (en) * 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
USRE38984E1 (en) * 1996-09-12 2006-02-14 Merck & Co., Inc. Antifungal combination therapy
ATE248625T1 (de) * 1996-09-12 2003-09-15 Merck & Co Inc Fungizide kombinationstherapie
US5854212A (en) * 1996-10-23 1998-12-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
US5936062A (en) * 1997-06-12 1999-08-10 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
AU6564000A (en) * 1999-07-27 2001-02-13 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AR035808A1 (es) * 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
US7214768B2 (en) * 2002-04-08 2007-05-08 Merck & Co., Inc. Echinocandin process
EP1654036B1 (en) * 2003-07-22 2007-12-26 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
EP1730180A4 (en) * 2004-02-24 2008-06-18 Commw Scient Ind Res Org ANTIFUNGAL PEPTIDES
EP1785432A1 (en) * 2005-11-15 2007-05-16 Sandoz AG Process and intermediates for the synthesis of caspofungin.
SI2049142T2 (sl) * 2006-07-26 2016-04-29 Sandoz Ag Formulacije kaspofungina
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
CA2692053A1 (en) * 2007-06-26 2008-12-31 Merck Sharp & Dohme Corp. Lyophilized anti-fungal composition
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
WO2009142761A1 (en) * 2008-05-21 2009-11-26 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Caspofungin bo free of caspofungin co
US8048853B2 (en) * 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
EP2240507A2 (en) * 2008-06-25 2010-10-20 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
EP2183271A1 (en) * 2008-06-25 2010-05-12 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Caspofungin free of caspofungin impurity a
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
TW201024322A (en) * 2008-12-31 2010-07-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate
WO2010108637A1 (en) 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN101602795B (zh) * 2009-07-20 2011-12-21 中国人民解放军第二军医大学 环六脂肽胺类抗真菌化合物及其盐类和制备方法
EP2463293A4 (en) * 2009-08-06 2013-06-05 Shanghai Techwell Biopharm Co AZACYCLOHEXAPEPTIDE BZW. ITS PHARMACEUTICAL ACCEPTABLE SALT, MANUFACTURING PROCESS AND USE
US8751760B2 (en) * 2009-10-01 2014-06-10 Dell Products L.P. Systems and methods for power state transitioning in an information handling system
CN101792486A (zh) * 2010-04-12 2010-08-04 浙江海正药业股份有限公司 一种合成醋酸卡泊芬净的方法
CN102219832B (zh) 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
HUE030464T2 (en) 2010-09-20 2017-05-29 Xellia Pharmaceuticals Aps Caspofungin preparation
JP6000254B2 (ja) * 2010-09-29 2016-09-28 上海天偉生物制薬有限公司 環状リポペプチド化合物又はその塩の精製方法
US8877777B2 (en) * 2010-09-30 2014-11-04 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
CN102367267B (zh) 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367269B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
KR101331984B1 (ko) 2010-12-09 2013-11-25 종근당바이오 주식회사 카스포펀진 제조방법 및 그의 신규 중간체
US20140005355A1 (en) * 2011-01-03 2014-01-02 Biocon Limited Process for preparation of caspofungin acetate and intermediates
CN102618606B (zh) * 2011-01-30 2014-09-10 浙江海正药业股份有限公司 一种棘白菌素生物转化方法
RS56426B1 (sr) 2011-03-03 2018-01-31 Cidara Therapeutics Inc Antigljivična sredstva i njihova upotreba
CN102746384B (zh) 2011-04-22 2016-01-20 上海天伟生物制药有限公司 一种高纯度的卡泊芬净或其盐及其制备方法和用途
TWI597293B (zh) 2011-04-28 2017-09-01 江蘇盛迪醫藥有限公司 用於合成卡帕芬淨的中間體及其製備方法
HUE063336T2 (hu) 2012-03-19 2024-01-28 Cidara Therapeutics Inc Adagolási rend echinokandin osztályba tartozó vegyületekhez
PT2922530T (pt) 2012-11-20 2016-12-22 Fresenius Kabi Usa Llc Formulações de acetato de caspofungina
CN112110991A (zh) * 2014-12-24 2020-12-22 上海天伟生物制药有限公司 一种含氮杂环六肽前体的组合物及其制备方法和用途
WO2017034961A1 (en) 2015-08-21 2017-03-02 Trilogy Therapeutics, Inc. Methods of treating lung infection with caspofungin
US10369188B2 (en) 2016-01-08 2019-08-06 Cidara Therapeutics, Inc. Methods for preventing and treating pneumocystis infections
EP3430400B1 (en) 2016-03-16 2023-06-21 Cidara Therapeutics, Inc. Dosing regimens for treatment of fungal infections
WO2017185030A1 (en) * 2016-04-22 2017-10-26 Fresenius Kabi Usa, Llc Caspofungin formulation with low impurities
EP3651801A4 (en) 2017-07-12 2021-04-07 Cidara Therapeutics, Inc. COMPOSITIONS AND METHODS OF TREATMENT OF MUSHROOM INFECTION
WO2019157453A1 (en) 2018-02-12 2019-08-15 Trilogy Therapeutics, Inc. Caspofungin compositions for inhalation
EP3620462A1 (en) 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Process for the preparation of caspofungin

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
BE851310A (fr) * 1976-02-12 1977-08-10 Sandoz Sa Nouveaux derives de la tetrahydro-equinocandine b
DE2742435A1 (de) * 1976-09-28 1978-04-06 Sandoz Ag Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
EP0030844A1 (en) * 1979-12-13 1981-06-24 Eli Lilly And Company Recovery process for A-30912 antibiotics
DE3030554A1 (de) * 1980-08-13 1982-03-25 Chemische Werke Hüls AG, 4370 Marl Einbrennlacke
US4931352A (en) * 1987-10-07 1990-06-05 Merck & Co., Inc. Antifungal fermentation product
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5194377A (en) * 1989-06-30 1993-03-16 Merck & Co., Inc. Antibiotic agent
NZ234225A (en) * 1989-06-30 1993-09-27 Merck & Co Inc Antibiotic from zalerion arboricola and its use as an antifungal agent and antipneumocystis agent
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
US5159059A (en) * 1990-05-29 1992-10-27 Merck & Co., Inc. Process for reduction of certain cyclohexapeptide compounds
NZ247149A (en) * 1992-03-19 1996-10-28 Lilly Co Eli Cyclic peptide antifungal agents and compositions thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds

Similar Documents

Publication Publication Date Title
RU95121639A (ru) Аза циклогексапептидные соединения
KR960701092A (ko) 아자 사이클로헥사펩타이드 화합물(Aza cyclohexapeptide compounds)
CA2061607A1 (en) 1-biphenylimidazole derivatives, their preparation and their therapeutic use
NZ332363A (en) substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
EP0632036A3 (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
ES2133324T3 (es) Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso.
IL106307A (en) Isoxazole derivatives for the treatment of irritable bowel syndrome
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
HU9202642D0 (en) Method for producing piperidine derivatives and pharmaceutical preparatives containing said compounds as active substance
ATE103585T1 (de) Polyamin-derivate als antineoplastische wirkstoffe.
KR900001715A (ko) Bu-3608 유도체
NO923413D0 (no) Terapeutiske benzazepin-forbindelser
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
GB8829593D0 (en) Novel compounds
GB1057667A (en) Substituted anthranilamides and process for the preparation thereof
IL81337A (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants,process for their preparation and pharmaceutical compositions containing them
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR910006322A (ko) 펩티딜 디플루오로디올 레닌 억제제
DE3665593D1 (en) Peptide immunostimulants
TW223065B (ru)
KR920011486A (ko) 항종양제